Cargando…

Exercise haemodynamics in heart failure with preserved ejection fraction: a systematic review and meta‐analysis

AIMS: Exercise right heart catheterization (RHC) is considered the gold‐standard test to diagnose heart failure with preserved ejection fraction (HFpEF). However, exercise RHC is an insufficiently standardized technique, and current haemodynamic thresholds to define HFpEF are not universally accepte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baratto, Claudia, Caravita, Sergio, Soranna, Davide, Dewachter, Céline, Bondue, Antoine, Zambon, Antonella, Badano, Luigi P., Parati, Gianfranco, Vachiéry, Jean‐Luc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715813/ https://www.ncbi.nlm.nih.gov/pubmed/35748109 http://dx.doi.org/10.1002/ehf2.13979

Ejemplares similares

An updated meta‐analysis of hemodynamics markers of prognosis in patients with pulmonary hypertension due to left heart disease
por: Baratto, Claudia, et al.
Publicado: (2022)

Haemodynamic validation of the three‐step HFA‐PEFF algorithm to diagnose heart failure with preserved ejection fraction
por: Lanzarone, Ettore, et al.
Publicado: (2023)

Impact of COVID‐19 lockdown on exercise capacity in PAH patients
por: Baratto, Claudia, et al.
Publicado: (2022)

Impact of severe secondary tricuspid regurgitation on rest and exercise hemodynamics of patients with heart failure and a preserved left ventricular ejection fraction
por: Baratto, Claudia, et al.
Publicado: (2023)

Pulmonary artery wedge pressure and left ventricular end-diastolic pressure during exercise in patients with dyspnoea
por: Baratto, Claudia, et al.
Publicado: (2023)

Clinical phenotypes and outcomes of pulmonary hypertension due to left heart disease: Role of the pre-capillary component
por: Caravita, Sergio, et al.
Publicado: (2018)

Association of outcome with left ventricular volumes and ejection fraction measured with two- and three-dimensional echocardiography in patients referred for routine, clinically indicated studies
por: Muraru, Denisa, et al.
Publicado: (2022)

Pulmonary arterial hypertension-associated genetic variants in combined post-capillary and pre-capillary pulmonary hypertension: a case report
por: L, Chomette, et al.
Publicado: (2021)

A Preclinical Rat Model of Heart Failure With Preserved Ejection Fraction With Multiple Comorbidities
por: Hubesch, Géraldine, et al.
Publicado: (2022)

Impact of reboxetine plus oxybutynin treatment for obstructive sleep apnea on cardiovascular autonomic modulation
por: Perger, Elisa, et al.
Publicado: (2023)

Early‐onset and severe pulmonary arterial hypertension due to a novel compound heterozygous association of rare VHL mutations: A case report and review of existing data
por: Chomette, Laura, et al.
Publicado: (2022)

Renal and intraglomerular haemodynamics in chronic heart failure with preserved and reduced ejection fraction
por: Jung, Susanne, et al.
Publicado: (2021)

Lung diffusion capacity correlates with pre‐implant pulmonary hypertension and predicts outcome after LVAD implantation
por: Macera, Francesca, et al.
Publicado: (2022)

Resting and exercise haemodynamic characteristics of patients with advanced heart failure and preserved ejection fraction
por: Deis, T., et al.
Publicado: (2021)

Clinical and Haemodynamic Effects of Arteriovenous Shunts in Patients with Heart Failure with Preserved Ejection Fraction
por: Soliman, Medhat, et al.
Publicado: (2022)

Riociguat in pulmonary hypertension and heart failure with preserved ejection fraction: the haemoDYNAMIC trial( )
por: Dachs, Theresa Marie, et al.
Publicado: (2022)

Effective Study: Development and Application of a Question‐Driven, Time‐Effective Cardiac Magnetic Resonance Scanning Protocol
por: Torlasco, Camilla, et al.
Publicado: (2021)

Identification of physiologic treatment targets with favourable haemodynamic consequences in heart failure with preserved ejection fraction
por: Kaye, David M., et al.
Publicado: (2020)

Comparison of haemodynamic response to muscle reflex in heart failure with reduced vs. preserved ejection fraction
por: Moriwaki, Keishi, et al.
Publicado: (2021)

The atrial secondary tricuspid regurgitation is associated to more favorable outcome than the ventricular phenotype
por: Gavazzoni, Mara, et al.
Publicado: (2022)

Corrigendum: The atrial secondary tricuspid regurgitation is associated to more favorable outcome than the ventricular phenotype
por: Gavazzoni, Mara, et al.
Publicado: (2023)

Functional Tricuspid Regurgitation and Atrial Fibrillation: Which Comes First, the Chicken or the Egg?
por: Muraru, Denisa, et al.
Publicado: (2020)

Risk stratification in heart failure with mild reduced ejection fraction
por: Magrì, Damiano, et al.
Publicado: (2020)

Persistent atrial fibrillation in heart failure with preserved ejection fraction: Prognostic relevance and association with clinical, imaging and invasive haemodynamic parameters
por: Schönbauer, Robert, et al.
Publicado: (2019)

Feasibility of Blood Pressure Measurement With a Wearable (Watch‐Type) Monitor During Impending Syncopal Episodes
por: Groppelli, Antonella, et al.
Publicado: (2022)

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019)

Heart failure with preserved ejection fraction
por: Rigolli, Marzia, et al.
Publicado: (2013)

Heart failure with preserved ejection fraction
por: ElGuindy, Ahmed, et al.
Publicado: (2012)

The kinocardiograph for assessment of changes in haemodynamic load in patients with chronic heart failure with reduced ejection fraction
por: Herkert, Cyrille, et al.
Publicado: (2021)

Biomarkers in heart failure with preserved ejection fraction
por: Meijers, W. C., et al.
Publicado: (2016)

Management of heart failure with preserved ejection fraction
por: Gard, Emma, et al.
Publicado: (2020)

Managing heart failure with preserved ejection fraction
por: Davidson, Alexander, et al.
Publicado: (2020)

Biomarkers in Heart Failure with Preserved Ejection Fraction
por: Bayes-Genis, Antoni, et al.
Publicado: (2022)

Comorbidities in heart failure with preserved ejection fraction
por: Deichl, Andrea, et al.
Publicado: (2022)

Sleep-disordered Breathing among Hospitalized Patients with COVID-19
por: Perger, Elisa, et al.
Publicado: (2021)

Alterations of Cardiovascular Complexity during Acute Exposure to High Altitude: A Multiscale Entropy Approach
por: Faini, Andrea, et al.
Publicado: (2019)

Metabolomic Fingerprint of Heart Failure with Preserved Ejection Fraction
por: Zordoky, Beshay N., et al.
Publicado: (2015)

Clinical Phenotypes in Heart Failure With Preserved Ejection Fraction
por: Samson, Rohan, et al.
Publicado: (2016)

Animal models of heart failure with preserved ejection fraction
por: Conceição, G., et al.
Publicado: (2016)

Cell Therapy for Heart Failure With Preserved Ejection Fraction
por: Borlaug, Barry A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_a4ckkt8mjea2t43u9fqk3pkgge